Industry Research Reports

Home > Reports > Medical Care > Hormonal Contraceptive - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Hormonal Contraceptive - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 114 Pages

Report ld: 2337124

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones.

The global market for Hormonal Contraceptive was estimated to be worth US$ 17480 million in 2023 and is forecast to a readjusted size of US$ 21910 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030

Hormonal Contraceptive Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Hormonal Contraceptive, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hormonal Contraceptive by region & country, by Type, and by Application.

The Hormonal Contraceptive market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Contraceptive.

Market Segmentation

Report Metric
Details
Report Title
Hormonal Contraceptive - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 21910 million
CAGR(2024-2030)
2.8%
Market Size Available for Years
2019-2030
Global Hormonal Contraceptive Companies Covered
Bayer AG, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer, Teva Pharmaceutical Industries, The Female Health Company, Organon International, Afaxys
Global Hormonal Contraceptive Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hormonal Contraceptive Market, Segment by Type
Oral Contraceptive Pills

Injectable Birth Control

Emergency Contraceptive Pills

Vaginal Rings

Transdermal Patches

Others
Global Hormonal Contraceptive Market, Segment by Application
Hospitals

Household

Clinics
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hormonal Contraceptive manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hormonal Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hormonal Contraceptive in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Hormonal Contraceptive Product Introduction
    1.2 Global Hormonal Contraceptive Market Size Forecast
    1.3 Hormonal Contraceptive Market Trends & Drivers
        1.3.1 Hormonal Contraceptive Industry Trends
        1.3.2 Hormonal Contraceptive Market Drivers & Opportunity
        1.3.3 Hormonal Contraceptive Market Challenges
        1.3.4 Hormonal Contraceptive Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Hormonal Contraceptive Players Revenue Ranking (2023)
    2.2 Global Hormonal Contraceptive Revenue by Company (2019-2024)
    2.3 Key Companies Hormonal Contraceptive Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Hormonal Contraceptive Product Offered
    2.5 Key Companies Time to Begin Mass Production of Hormonal Contraceptive
    2.6 Hormonal Contraceptive Market Competitive Analysis
        2.6.1 Hormonal Contraceptive Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Hormonal Contraceptive Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Contraceptive as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oral Contraceptive Pills
        3.1.2 Injectable Birth Control
        3.1.3 Emergency Contraceptive Pills
        3.1.4 Vaginal Rings
        3.1.5 Transdermal Patches
        3.1.6 Others
    3.2 Global Hormonal Contraceptive Sales Value by Type
        3.2.1 Global Hormonal Contraceptive Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Hormonal Contraceptive Sales Value, by Type (2019-2030)
        3.2.3 Global Hormonal Contraceptive Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Household
        4.1.3 Clinics
    4.2 Global Hormonal Contraceptive Sales Value by Application
        4.2.1 Global Hormonal Contraceptive Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Hormonal Contraceptive Sales Value, by Application (2019-2030)
        4.2.3 Global Hormonal Contraceptive Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Hormonal Contraceptive Sales Value by Region
        5.1.1 Global Hormonal Contraceptive Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Hormonal Contraceptive Sales Value by Region (2019-2024)
        5.1.3 Global Hormonal Contraceptive Sales Value by Region (2025-2030)
        5.1.4 Global Hormonal Contraceptive Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Hormonal Contraceptive Sales Value, 2019-2030
        5.2.2 North America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Hormonal Contraceptive Sales Value, 2019-2030
        5.3.2 Europe Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Hormonal Contraceptive Sales Value, 2019-2030
        5.4.2 Asia Pacific Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Hormonal Contraceptive Sales Value, 2019-2030
        5.5.2 South America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Hormonal Contraceptive Sales Value, 2019-2030
        5.6.2 Middle East & Africa Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Hormonal Contraceptive Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Hormonal Contraceptive Sales Value
    6.3 United States
        6.3.1 United States Hormonal Contraceptive Sales Value, 2019-2030
        6.3.2 United States Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Hormonal Contraceptive Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Hormonal Contraceptive Sales Value, 2019-2030
        6.4.2 Europe Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Hormonal Contraceptive Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Hormonal Contraceptive Sales Value, 2019-2030
        6.5.2 China Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Hormonal Contraceptive Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Hormonal Contraceptive Sales Value, 2019-2030
        6.6.2 Japan Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Hormonal Contraceptive Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Hormonal Contraceptive Sales Value, 2019-2030
        6.7.2 South Korea Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Hormonal Contraceptive Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Hormonal Contraceptive Sales Value, 2019-2030
        6.8.2 Southeast Asia Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Hormonal Contraceptive Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Hormonal Contraceptive Sales Value, 2019-2030
        6.9.2 India Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bayer AG
        7.1.1 Bayer AG Profile
        7.1.2 Bayer AG Main Business
        7.1.3 Bayer AG Hormonal Contraceptive Products, Services and Solutions
        7.1.4 Bayer AG Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.1.5 Bayer AG Recent Developments
    7.2 Johnson and Johnson
        7.2.1 Johnson and Johnson Profile
        7.2.2 Johnson and Johnson Main Business
        7.2.3 Johnson and Johnson Hormonal Contraceptive Products, Services and Solutions
        7.2.4 Johnson and Johnson Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.2.5 Johnson and Johnson Recent Developments
    7.3 Mayer Laboratories
        7.3.1 Mayer Laboratories Profile
        7.3.2 Mayer Laboratories Main Business
        7.3.3 Mayer Laboratories Hormonal Contraceptive Products, Services and Solutions
        7.3.4 Mayer Laboratories Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.3.5 Merck and Co Recent Developments
    7.4 Merck and Co
        7.4.1 Merck and Co Profile
        7.4.2 Merck and Co Main Business
        7.4.3 Merck and Co Hormonal Contraceptive Products, Services and Solutions
        7.4.4 Merck and Co Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.4.5 Merck and Co Recent Developments
    7.5 Mylan N.V.
        7.5.1 Mylan N.V. Profile
        7.5.2 Mylan N.V. Main Business
        7.5.3 Mylan N.V. Hormonal Contraceptive Products, Services and Solutions
        7.5.4 Mylan N.V. Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.5.5 Mylan N.V. Recent Developments
    7.6 Pfizer
        7.6.1 Pfizer Profile
        7.6.2 Pfizer Main Business
        7.6.3 Pfizer Hormonal Contraceptive Products, Services and Solutions
        7.6.4 Pfizer Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.6.5 Pfizer Recent Developments
    7.7 Teva Pharmaceutical Industries
        7.7.1 Teva Pharmaceutical Industries Profile
        7.7.2 Teva Pharmaceutical Industries Main Business
        7.7.3 Teva Pharmaceutical Industries Hormonal Contraceptive Products, Services and Solutions
        7.7.4 Teva Pharmaceutical Industries Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.7.5 Teva Pharmaceutical Industries Recent Developments
    7.8 The Female Health Company
        7.8.1 The Female Health Company Profile
        7.8.2 The Female Health Company Main Business
        7.8.3 The Female Health Company Hormonal Contraceptive Products, Services and Solutions
        7.8.4 The Female Health Company Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.8.5 The Female Health Company Recent Developments
    7.9 Organon International
        7.9.1 Organon International Profile
        7.9.2 Organon International Main Business
        7.9.3 Organon International Hormonal Contraceptive Products, Services and Solutions
        7.9.4 Organon International Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.9.5 Organon International Recent Developments
    7.10 Afaxys
        7.10.1 Afaxys Profile
        7.10.2 Afaxys Main Business
        7.10.3 Afaxys Hormonal Contraceptive Products, Services and Solutions
        7.10.4 Afaxys Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)
        7.10.5 Afaxys Recent Developments

 8 Industry Chain Analysis
    8.1 Hormonal Contraceptive Industrial Chain
    8.2 Hormonal Contraceptive Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Hormonal Contraceptive Sales Model
        8.5.2 Sales Channel
        8.5.3 Hormonal Contraceptive Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Hormonal Contraceptive Market Trends
    Table 2. Hormonal Contraceptive Market Drivers & Opportunity
    Table 3. Hormonal Contraceptive Market Challenges
    Table 4. Hormonal Contraceptive Market Restraints
    Table 5. Global Hormonal Contraceptive Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Hormonal Contraceptive Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Hormonal Contraceptive Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Hormonal Contraceptive Product Type
    Table 9. Key Companies Time to Begin Mass Production of Hormonal Contraceptive
    Table 10. Global Hormonal Contraceptive Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Contraceptive as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Hormonal Contraceptive Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Hormonal Contraceptive Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Hormonal Contraceptive Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Hormonal Contraceptive Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Hormonal Contraceptive Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Hormonal Contraceptive Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Hormonal Contraceptive Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Hormonal Contraceptive Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Hormonal Contraceptive Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Hormonal Contraceptive Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Hormonal Contraceptive Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Hormonal Contraceptive Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Hormonal Contraceptive Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Hormonal Contraceptive Sales Value by Region (2019-2024) & (%)
    Table 27. Global Hormonal Contraceptive Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Hormonal Contraceptive Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Hormonal Contraceptive Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Hormonal Contraceptive Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bayer AG Basic Information List
    Table 32. Bayer AG Description and Business Overview
    Table 33. Bayer AG Hormonal Contraceptive Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Hormonal Contraceptive Business of Bayer AG (2019-2024)
    Table 35. Bayer AG Recent Developments
    Table 36. Johnson and Johnson Basic Information List
    Table 37. Johnson and Johnson Description and Business Overview
    Table 38. Johnson and Johnson Hormonal Contraceptive Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Hormonal Contraceptive Business of Johnson and Johnson (2019-2024)
    Table 40. Johnson and Johnson Recent Developments
    Table 41. Mayer Laboratories Basic Information List
    Table 42. Mayer Laboratories Description and Business Overview
    Table 43. Mayer Laboratories Hormonal Contraceptive Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Hormonal Contraceptive Business of Mayer Laboratories (2019-2024)
    Table 45. Mayer Laboratories Recent Developments
    Table 46. Merck and Co Basic Information List
    Table 47. Merck and Co Description and Business Overview
    Table 48. Merck and Co Hormonal Contraceptive Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Hormonal Contraceptive Business of Merck and Co (2019-2024)
    Table 50. Merck and Co Recent Developments
    Table 51. Mylan N.V. Basic Information List
    Table 52. Mylan N.V. Description and Business Overview
    Table 53. Mylan N.V. Hormonal Contraceptive Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Hormonal Contraceptive Business of Mylan N.V. (2019-2024)
    Table 55. Mylan N.V. Recent Developments
    Table 56. Pfizer Basic Information List
    Table 57. Pfizer Description and Business Overview
    Table 58. Pfizer Hormonal Contraceptive Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Hormonal Contraceptive Business of Pfizer (2019-2024)
    Table 60. Pfizer Recent Developments
    Table 61. Teva Pharmaceutical Industries Basic Information List
    Table 62. Teva Pharmaceutical Industries Description and Business Overview
    Table 63. Teva Pharmaceutical Industries Hormonal Contraceptive Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Hormonal Contraceptive Business of Teva Pharmaceutical Industries (2019-2024)
    Table 65. Teva Pharmaceutical Industries Recent Developments
    Table 66. The Female Health Company Basic Information List
    Table 67. The Female Health Company Description and Business Overview
    Table 68. The Female Health Company Hormonal Contraceptive Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Hormonal Contraceptive Business of The Female Health Company (2019-2024)
    Table 70. The Female Health Company Recent Developments
    Table 71. Organon International Basic Information List
    Table 72. Organon International Description and Business Overview
    Table 73. Organon International Hormonal Contraceptive Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Hormonal Contraceptive Business of Organon International (2019-2024)
    Table 75. Organon International Recent Developments
    Table 76. Afaxys Basic Information List
    Table 77. Afaxys Description and Business Overview
    Table 78. Afaxys Hormonal Contraceptive Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Hormonal Contraceptive Business of Afaxys (2019-2024)
    Table 80. Afaxys Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Hormonal Contraceptive Downstream Customers
    Table 84. Hormonal Contraceptive Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Hormonal Contraceptive Product Picture
    Figure 2. Global Hormonal Contraceptive Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)
    Figure 4. Hormonal Contraceptive Report Years Considered
    Figure 5. Global Hormonal Contraceptive Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hormonal Contraceptive Revenue in 2023
    Figure 7. Hormonal Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Oral Contraceptive Pills Picture
    Figure 9. Injectable Birth Control Picture
    Figure 10. Emergency Contraceptive Pills Picture
    Figure 11. Vaginal Rings Picture
    Figure 12. Transdermal Patches Picture
    Figure 13. Others Picture
    Figure 14. Global Hormonal Contraceptive Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Hormonal Contraceptive Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Household
    Figure 18. Product Picture of Clinics
    Figure 19. Global Hormonal Contraceptive Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Hormonal Contraceptive Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Hormonal Contraceptive Sales Value (%), (2019-2030)
    Figure 32. United States Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030
    Figure 53. Hormonal Contraceptive Industrial Chain
    Figure 54. Hormonal Contraceptive Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation

Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones.

The global market for Hormonal Contraceptive was estimated to be worth US$ 17480 million in 2023 and is forecast to a readjusted size of US$ 21910 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030

Market Segmentation

Industry: Medical Care

Published: 2024-01-24

Pages: 114 Pages

Report ld: 2337124

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00